[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Leite et al., 2021 - Google Patents

Combined transcriptome and proteome leukocyte's profiling reveals up-regulated module of genes/proteins related to low density neutrophils and impaired …

Leite et al., 2021

View HTML
Document ID
17970942794040431647
Author
Leite G
Ferreira B
Tashima A
Nishiduka E
Cunha-Neto E
Brunialti M
Assuncao M
Azevedo L
Freitas F
van der Poll T
Scicluna B
Salomão R
Publication year
Publication venue
Frontiers in immunology

External Links

Snippet

Sepsis is a global health emergency, which is caused by various sources of infection that lead to changes in gene expression, protein-coding, and metabolism. Advancements in “omics” technologies have provided valuable tools to unravel the mechanisms involved in …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions

Similar Documents

Publication Publication Date Title
Aschenbrenner et al. An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells
Leite et al. Combined transcriptome and proteome leukocyte’s profiling reveals up-regulated module of genes/proteins related to low density neutrophils and impaired transcription and translation processes in clinical sepsis
Daamen et al. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
Vanderbeke et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
Li et al. Whole‐transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID‐19 patients
Saris et al. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
Schmiedel et al. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types
Boucheron et al. CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2
Giannella et al. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients
Errington et al. A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach
Graessel et al. A combined omics approach to generate the surface atlas of human naive CD4+ T cells during early T-cell receptor activation
Malengier-Devlies et al. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
Li et al. New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation
Martin-Sanchez et al. Immunological biomarkers of fatal COVID-19: a study of 868 patients
Garcia-Gonzalez et al. Dysregulated immune responses in COVID-19 patients correlating with disease severity and invasive oxygen requirements
Moorlag et al. Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity
Rice et al. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19
Zhou et al. Quantitative proteomic profile of psoriatic epidermis identifies OAS2 as a novel biomarker for disease activity
Wang et al. LOC152742 as a biomarker in the diagnosis of pulmonary tuberculosis infection
Schubert et al. A multi-omics analysis of mucosal-Associated-Invariant T cells reveals key drivers of distinct modes of activation
Sfikakis et al. Blood transcriptomes of anti-SARS-CoV-2 antibody-positive healthy individuals who experienced asymptomatic versus clinical infection
Meng et al. MX2: Identification and systematic mechanistic analysis of a novel immune-related biomarker for systemic lupus erythematosus
Bingham et al. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis
Sumida et al. An autoimmune transcriptional circuit drives FOXP3+ regulatory T cell dysfunction
Lee et al. Role of lymphoid lineage cells aberrantly expressing alarmins S100A8/A9 in determining the severity of COVID-19